Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaenia

European Journal of Cancer

Volumn 45, Issue 4, 2009, Pages 505-512

  Frakking, Florine N J ^a   Brouwer, Nannette ^b   van de Wetering, Marianne D ^a   Budde, Ilona Kleine ^c   Strengers, Paul F W ^c   Huitema, Alwin D ^d   Laursen, Inga ^e   Houen, Gunnar ^e   Caron, Huib N ^a   Dolman, Koert M ^a,b   Kuijpers, Taco W ^a,b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c Departments of Medical Psychology   (Netherlands)

^d SLOTERVAART HOSPITAL   (Netherlands)

^e STATENS SERUM INSTITUT   (Denmark)

Author keywords

Chemotherapy; Mannose binding lectin; Pharmacokinetics; Phase II trial

Indexed keywords

MANNOSE BINDING LECTIN;

ADOLESCENT; ARTICLE; BODY WEIGHT; CHEMOTHERAPY INDUCED NEUTROPENIA; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG SAFETY; FEMALE; FEVER; HALF LIFE TIME; HUMAN; INFANT; MALE; NEUTROPENIA; NEWBORN; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SHORT LASTING FEVER; SUBSTITUTION THERAPY;

ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MANNOSE-BINDING LECTIN; NEUTROPENIA; PATIENT SELECTION; PROSPECTIVE STUDIES;

EID: 60149092031     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.11.036     Document Type: Article

References (27)

1. Turner M.W. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 17 11 (1996) 532-540
2. Steffensen R., Thiel S., Varming K., Jersild C., and Jensenius J.C. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Meth 241 1-2 (2000) 33-42
3. Taylor M.E., Brickell P.M., Craig R.K., and Summerfield J.A. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. Biochem J 262 3 (1989) 763-771
4. Brouwer N., Dolman K.M., van Zwieten R., et al. Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop. Mol Immunol 43 13 (2006) 2051-2060
5. Madsen H.O., Garred P., Thiel S., et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 155 6 (1995) 3013-3020
6. Turner M.W., and Hamvas R.M. Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2 3 (2000) 305-322
7. Super M., Thiel S., Lu J., Levinsky R.J., and Turner M.W. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 2 8674 (1989) 1236-1239
8. Neth O., Hann I., Turner M.W., and Klein N.J. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 358 9282 (2001) 614-618
9. Mullighan C.G., Heatley S., Doherty K., et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 99 10 (2002) 3524-3529
10. Peterslund N.A., Koch C., Jensenius J.C., and Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 358 9282 (2001) 637-638
11. Valdimarsson H., Vikingsdottir T., and Bang P. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol 59 1 (2004) 97-102
12. Petersen K.A., Matthiesen F., Agger T., et al. Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin. J Clin Immunol 26 5 (2006) 465-475
13. Laursen I. Mannan-binding lectin (MBL) production from human plasma. Biochem Soc Trans 31 Pt 4 (2003) 758-762
14. Frakking F.N., van de Wetering M.D., Brouwer N., et al. The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia. Eur J Cancer 42 7 (2006) 909-916
15. Tacx A.N., Groeneveld A.B., Hart M.H., Aarden L.A., and Hack C.E. Mannan binding lectin in febrile adults: no correlation with microbial infection and complement activation. J Clin Pathol 56 12 (2003) 956-959
16. Karlsson M.O., and Sheiner L.B. The importance of modeling interoccasion variability in population pharmacokinetic analyses. J Pharmacokinet Biopharm 21 6 (1993) 735-750
17. Anderson B.J., and Holford N.H. Mechanism-based concepts of size and maturity in pharmacokinetics. Ann Rev Pharmacol Toxicol (2007)
18. Jonsson E.N., and Karlsson M.O. Xpose - an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput Meth Programs Biomed 58 1 (1999) 51-64
19. Karlsson M.O., and Savic R.M. Diagnosing model diagnostics. Clin Pharmacol Ther 82 1 (2007) 17-20
20. Jensen P.H., Weilguny D., Matthiesen F., McGuire K.A., Shi L., and Hojrup P. Characterization of the oligomer structure of recombinant human mannan-binding lectin. J Biol Chem 280 12 (2005) 11043-11051
21. Garred P., Pressler T., Lanng S., et al. Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease. Pediatr Pulmonol 33 3 (2002) 201-207
22. Valdimarsson H., Stefansson M., Vikingsdottir T., et al. Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand J Immunol 48 2 (1998) 116-123
23. Shi L., Takahashi K., Dundee J., et al. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 199 10 (2004) 1379-1390
24. Bergmann O.J., Christiansen M., Laursen I., et al. Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. Eur J Haematol 70 2 (2003) 91-97
25. Lausen B., Schmiegelow K., Andreassen B., Madsen H.O., and Garred P. Infections during induction therapy of childhood acute lymphoblastic leukemia - no association to mannose-binding lectin deficiency. Eur J Haematol 76 6 (2006) 481-487
26. Frakking F.N., Brouwer N., van Eijkelenburg N.K., et al. Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis. Clin Exp Immunol 150 2 (2007) 255-262
27. Garred P., Pressler T., Madsen H.O., et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 104 4 (1999) 431-437